Soluble HLA-G (sHLA-G) has been reported as a biomarker for embryo quality in human in vitro fertilization (IVF). The first report showed that some embryos had secreted sHLA-G and that the secretion was necessary for implantation. If these data are true, sHLA-G could be a very useful marker for embryo selection. However, one major limitation of the report was a distinct lack of controls relevant to the methods of measurement. Therefore, we re-examined the detection of sHLA-G in 109 culture supernatants from embryos fertilized in vitro. We were unable to detect sHLA-G in any supernatant despite using a more sensitive method than that used in the previous report. We further explored other reports that had shown positive data of sHLA-G secretion from embryos, and found that neither standard curves to enable calculation of sHLA-G concentration correctly nor any data for calibration were available in these reports. In this review, we point out several problems with the detection of sHLA-G in the previous reports, and describe controls and methods that can be used to determine sHLA-G concentrations accurately.
How to translate text using browser tools
1 April 2008
Can Soluble HLA-G Protein Be a Marker for the Selection of IVF Embryos
Akiko Ishitani,
Noriko Sageshima,
Mari Nakanishi,
Katsuhiko Hatake
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.
Journal of Mammalian Ova Research
Vol. 25 • No. 1
April 2008
Vol. 25 • No. 1
April 2008
ELISA
embryo
Soluble HLA-G